Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tryptophan hydroxylase (TPH) is an enzyme that catalyzes the rate-limiting step in the biosynthesis of serotonin and melatonin. There are two main isoforms in humans: TPH1, primarily expressed in peripheral tissues, and TPH2, mainly found in serotonergic neurons of the brainstem raphe nuclei. TPH catalyzes the monooxygenation of tryptophan to produce 5-hydroxytryptophan, using tetrahydrobiopterin (BH₄) and molecular oxygen as cofactors. Alterations or inhibition of TPH can significantly affect serotonin levels.
Modulation of Tryptophan Hydroxylase activity affects serotonin levels, influencing neuronal signaling and mood regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tryptophan Hydroxylase (None).